FRESENIUS MEDICAL CARE AG
Income Statement
| Line Item | FY2014 | FY2013 |
|---|---|---|
| Revenue | $5.27B | $4.97B |
| Cost of Revenue | $10.84B | $9.87B |
| Gross Profit | $5.00B | $4.74B |
| Gross Margin | 94.9% | 95.3% |
| Operating Expenses | ||
| Research & Development | $122.1M | $125.8M |
| SG&A Expense | $2.64B | $2.38B |
| Operating Income | $2.25B | $2.26B |
| Operating Margin | 42.8% | 45.4% |
| Interest Expense | $495.4M | $447.5M |
| Pretax Income | $1.84B | $1.85B |
| Income Tax Expense | $583.6M | $592.0M |
| Net Income | $1.05B | $1.11B |
| Net Margin | 19.9% | 22.3% |
| EPS (Basic) | $3.46 | $3.65 |
| EPS (Diluted) | $3.45 | $3.65 |
| Shares Outstanding (Basic) | 302.3M | 301.9M |
| Shares Outstanding (Diluted) | 302.9M | 302.6M |
| Dividends Per Share | $0.77 | — |